(Q46897065)

26 December 2017

title

Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation (English)

1 reference

26 December 2017

0 references

1 reference

Viktor Umansky

1

1 reference

26 December 2017

Alexandra Sevko

series ordinal

2

1 reference

26 December 2017

publication date

27 November 2011

1 reference

26 December 2017

Cancer Immunology, Immunotherapy

published in

1 reference

26 December 2017

volume

61

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

275-282

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00262-011-1164-6

exact match

0 references

cites work

Epidemiology of invasive cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Strategies to overcome obstacles to successful immunotherapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Melanoma immunology: past, present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Downregulation of tapasin expression in progressive human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

New views on natural killer cell-based immunotherapy for melanoma treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Immune surveillance: a balance between protumor and antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Autocrine and paracrine regulation by cytokines and growth factors in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Inflammation meets cancer, with NF-κB as the matchmaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Infection, immunoregulation, and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Epidemiologic perspective on immune-surveillance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Molecular Pathways Linking Inflammation and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Chemokines in cancer related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Chronic inflammation, immunosuppression and cancer: new insights and outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Humoral immunity, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

The RTK/RAS/BRAF/PI3K pathways in melanoma: biology, small molecule inhibitors, and potential applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

The genetics of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

RET proto-oncogene in the development of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Sustained exposure to bacterial antigen induces interferon-γ-dependent T cell receptor ζ down-regulation and impaired T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Regulation of immune responses by L-arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Nitric oxide-induced apoptosis in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Nitric oxide and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Regulation of T cell receptor CD3zeta chain expression by L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Therapeutic targeting of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Modulators of arginine metabolism support cancer immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Viagra (sildenafil citrate) and ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Combined chemoimmunotherapy of solid tumours: improving vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Immune parameters affecting the efficacy of chemotherapeutic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1164-6

10.1007/S00262-011-1164-6

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017